Published in Eur J Biochem on June 01, 1999
Phospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention. Chem Rev (2011) 2.48
First pass annotation of promoters on human chromosome 22. Genome Res (2001) 1.99
Phospholipase A2 biochemistry. Cardiovasc Drugs Ther (2008) 1.93
Docosahexaenoic acid and arachidonic acid release in rat brain astrocytes is mediated by two separate isoforms of phospholipase A2 and is differently regulated by cyclic AMP and Ca2+. Br J Pharmacol (2003) 1.50
Insulin secretory responses and phospholipid composition of pancreatic islets from mice that do not express Group VIA phospholipase A2 and effects of metabolic stress on glucose homeostasis. J Biol Chem (2006) 1.41
Localizing the membrane binding region of Group VIA Ca2+-independent phospholipase A2 using peptide amide hydrogen/deuterium exchange mass spectrometry. J Biol Chem (2009) 1.23
Group VIA phospholipase A2 (iPLA2beta) participates in angiotensin II-induced transcriptional up-regulation of regulator of g-protein signaling-2 in vascular smooth muscle cells. J Biol Chem (2007) 1.16
Effects of stable suppression of Group VIA phospholipase A2 expression on phospholipid content and composition, insulin secretion, and proliferation of INS-1 insulinoma cells. J Biol Chem (2005) 1.13
Attenuated free cholesterol loading-induced apoptosis but preserved phospholipid composition of peritoneal macrophages from mice that do not express group VIA phospholipase A2. J Biol Chem (2007) 1.10
Membranes serve as allosteric activators of phospholipase A2, enabling it to extract, bind, and hydrolyze phospholipid substrates. Proc Natl Acad Sci U S A (2015) 0.93
Genetic ablation of calcium-independent phospholipase A(2)beta causes hypercontractility and markedly attenuates endothelium-dependent relaxation to acetylcholine. Am J Physiol Heart Circ Physiol (2010) 0.90
Group VIA Ca2+-independent phospholipase A2 (iPLA2beta) and its role in beta-cell programmed cell death. Biochimie (2010) 0.90
Phospholipase A2 activation as a therapeutic approach for cognitive enhancement in early-stage Alzheimer disease. Psychopharmacology (Berl) (2008) 0.86
Cholinergic and glutamatergic alterations beginning at the early stages of Alzheimer disease: participation of the phospholipase A2 enzyme. Psychopharmacology (Berl) (2008) 0.86
Skeletal muscle group VIA phospholipase A2 (iPLA2beta): expression and role in fatty acid oxidation. Biochemistry (2008) 0.83
Calcium-independent phospholipase A2 in rabbit ventricular myocytes. Lipids (2008) 0.82
Membrane and inhibitor interactions of intracellular phospholipases A2. Adv Biol Regul (2015) 0.80
Expression of PLA2G6 in human fetal development: Implications for infantile neuroaxonal dystrophy. Brain Res Bull (2010) 0.79
Inhibition of phospholipase A2 in rat brain decreases the levels of total Tau protein. J Neural Transm (Vienna) (2011) 0.77
Chronic inhibition of brain phospholipase A2 in adult rats impairs the survival of newborn mature neurons in the hippocampus. J Neural Transm (Vienna) (2014) 0.76
Development of Potent and Selective Inhibitors for Group VIA Calcium-Independent Phospholipase A2 Guided by Molecular Dynamics and Structure-Activity Relationships. J Med Chem (2016) 0.76
Identification of Novel Compound Mutations in PLA2G6-Associated Neurodegeneration Patient with Characteristic MRI Imaging. Mol Neurobiol (2016) 0.76
Conditioning training and retrieval increase phospholipase A(2) activity in the cerebral cortex of rats. J Neural Transm (Vienna) (2008) 0.75
Social capital, income inequality, and mortality. Am J Public Health (1997) 14.28
Social capital and self-rated health: a contextual analysis. Am J Public Health (1999) 8.54
Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science (1999) 7.84
Health and social cohesion: why care about income inequality? BMJ (1997) 4.71
State-level income inequality and individual mortality risk: a prospective, multilevel study. Am J Public Health (2001) 3.77
The relationship of income inequality to mortality: does the choice of indicator matter? Soc Sci Med (1997) 3.69
Income inequality and health: pathways and mechanisms. Health Serv Res (1999) 3.68
Social capital: a guide to its measurement. Health Place (1999) 3.45
Crime: social disorganization and relative deprivation. Soc Sci Med (1999) 3.09
Does the state you live in make a difference? Multilevel analysis of self-rated health in the US. Soc Sci Med (2001) 3.01
State income inequality, household income, and maternal mental and physical health: cross sectional national survey. BMJ (2000) 2.18
Socioeconomic inequality in voting participation and self-rated health. Am J Public Health (2001) 1.85
Women's status and the health of women and men: a view from the States. Soc Sci Med (1999) 1.85
What is the lag time between income inequality and health status? J Epidemiol Community Health (2000) 1.76
Multiple splice variants of the human calcium-independent phospholipase A2 and their effect on enzyme activity. J Biol Chem (1998) 1.67
Overexpression of human prostaglandin G/H synthase-1 and -2 by recombinant vaccinia virus: inhibition by nonsteroidal anti-inflammatory drugs and biosynthesis of 15-hydroxyeicosatetraenoic acid. Mol Pharmacol (1994) 1.49
Altered states of consciousness therapy. A missing component in alcohol and drug rehabilitation treatment. J Subst Abuse Treat (1991) 1.46
Serum-coated zymosan stimulates the synthesis of leukotriene B4 in human polymorphonuclear leukocytes. Inhibition by cyclic AMP. Biochem Biophys Res Commun (1981) 1.45
Study of conditions of production of roquefortine and other metabolites of Penicillin roqueforti. Appl Environ Microbiol (1977) 1.30
Stimulation of human leukocyte degranulation by leukotriene B4 and its omega-oxidized metabolites. FEBS Lett (1981) 1.30
The gene for rat atrial natriuretic factor. J Biol Chem (1985) 1.25
Attenuation of adhesion-dependent signaling and cell spreading in transformed fibroblasts lacking protein tyrosine phosphatase-1B. J Biol Chem (2001) 1.23
Ecological analysis of teen birth rates: association with community income and income inequality. Matern Child Health J (2001) 1.20
Regulation of attention to novel stimuli by frontal lobes: an event-related potential study. Neuroreport (1998) 1.17
DNA-protein interactions in the Caenorhabditis elegans embryo: oocyte and embryonic factors that bind to the promoter of the gut-specific ges-1 gene. Dev Biol (1994) 1.14
Catecholamine storage vesicle protein expression in genetic hypertension. Blood Press (1999) 1.07
On the expression and regulation of 5-lipoxygenase in human lymphocytes. Proc Natl Acad Sci U S A (1992) 1.05
Lysophosphatidylcholine (LPC) induces proinflammatory cytokines by a platelet-activating factor (PAF) receptor-dependent mechanism. Clin Exp Immunol (1999) 1.03
Functional identification of the active-site nucleophile of the human 85-kDa cytosolic phospholipase A2. Biochemistry (1996) 1.02
Lymphocyte subset redistribution in response to acute experimental stress: effects of gender, ethnicity, hypertension, and the sympathetic nervous system. Brain Behav Immun (1995) 1.02
The corpus callosum and lateral ventricles in children with attention-deficit hyperactivity disorder: a brain magnetic resonance imaging study. Biol Psychiatry (1996) 1.01
Firearm prevalence and social capital. Ann Epidemiol (2001) 1.00
Acid-soluble nuclear proteins of the testis during spermatogenesis in the winter flounder. Loss of the high mobility group proteins. J Biol Chem (1980) 0.95
Purification and characterization of recombinant human cyclooxygenase-2. Arch Biochem Biophys (1994) 0.95
Selective inhibition of cyclooxygenase-1 and -2 using intact insect cell assays. Biochem Pharmacol (1996) 0.93
Leukotrienes stimulate initiation of DNA synthesis in cultured arterial smooth muscle cells. J Cell Sci (1987) 0.93
Cysteinyl leukotrienes enhance growth of human airway epithelial cells. Am J Physiol (1990) 0.92
The YRD motif is a major determinant of substrate and inhibitor specificity in T-cell protein-tyrosine phosphatase. J Biol Chem (2001) 0.91
Are many Z-DNA binding proteins actually phospholipid-binding proteins? Proc Natl Acad Sci U S A (1990) 0.88
Opsonized bacteria stimulate leukotriene synthesis in human leukocytes. Biochim Biophys Acta (1985) 0.87
The effects of the menstrual cycle, race, and gender on adrenergic receptors and agonists. Clin Pharmacol Ther (1996) 0.87
Cardiac atria and ventricles contain different inducible adrenaline synthesising enzymes. Cardiovasc Res (1990) 0.87
Alignment of rat cardionatrin sequences with the preprocardionatrin sequence from complementary DNA. Science (1985) 0.86
Cytochalasins A and B from strains of Phoma exigua var. exigua and formation of cytochalasin B in potato gangrene. J Gen Microbiol (1975) 0.86
Expression of phospholipase A2 isoforms in human normal and atherosclerotic arterial wall. Arterioscler Thromb Vasc Biol (1997) 0.86
Human B lymphocytes possess 5-lipoxygenase activity and convert arachidonic acid to leukotriene B4. Biochem Biophys Res Commun (1991) 0.85
Yolk proteins from nematodes, chickens, and frogs bind strongly and preferentially to left-handed Z-DNA. J Biol Chem (1988) 0.85
Selenite incubated with NADPH and mammalian thioredoxin reductase yields selenide, which inhibits lipoxygenase and changes the electron spin resonance spectrum of the active site iron. Biochemistry (1996) 0.85
Endogenous opioid inhibition and facilitation of gonadotropin-releasing hormone release from the median eminence in vitro: potential role of catecholamines. Endocrinology (1988) 0.85
Factitious pheochromocytoma: novel mimickry by Valsalva maneuver and clues to diagnosis. Am J Hypertens (1995) 0.84
Pathways between area-level income inequality and increased mortality in U.S. men. Ann N Y Acad Sci (1999) 0.84
On the interrelationship of prostaglandin endoperoxide G2 and cyclic nucleotides in platelet function. Eur J Biochem (1977) 0.84
Studies on the regulation and localization of 5-lipoxygenase in human B-lymphocytes. Eur J Biochem (1995) 0.84
Refinement of an in vitro cell model for cytochrome P450 induction. Drug Metab Dispos (1998) 0.84
Genomic characterization of the human and mouse protein tyrosine phosphatase-1B genes. Gene (2000) 0.84
Stimulation of human myelopoiesis by leukotriene B4. Biochem Biophys Res Commun (1985) 0.83
Neuropsychologically impaired alcoholics: assessment, treatment considerations, and rehabilitation. J Subst Abuse Treat (1988) 0.83
On the expression of cytosolic calcium-independent phospholipase A2 (88kDa) in immature and mature myeloid cells and its role in leukotriene synthesis in human granulocytes. FEBS Lett (1998) 0.83
Human B and T lymphocytes convert leukotriene A4 into leukotriene B4. Biochem Biophys Res Commun (1988) 0.83
Enantioselective activation of the peroxisome proliferator-activated receptor. J Biol Chem (1993) 0.83
Ethanol-enhanced transmembrane penetration of arachidonic acid and activation of the 5-lipoxygenase pathway in human leukocytes. Biochem Biophys Res Commun (1986) 0.82
Effects of monocyte-lymphocyte interaction on the synthesis of leukotriene B4. Eur J Biochem (1991) 0.82
On the mechanism of induction of DNA synthesis in cultured arterial smooth muscle cells by leukotrienes. Possible role of prostaglandin endoperoxide synthase products and platelet-derived growth factor. J Cell Sci (1991) 0.82
Stimulation of arachidonic acid release and prostaglandin production in 3T3 fibroblasts by adenosine 3':5'-monophosphate. Adv Prostaglandin Thromboxane Res (1978) 0.82
Leukotriene A4 hydrolase in the human B-lymphocytic cell line Raji: indications of catalytically divergent forms of the enzyme. Arch Biochem Biophys (1991) 0.81
Elevation of adenosine 3',5'-monophosphate levels in 3T3 fibroblasts by arachidonic acid: evidence for mediation by prostaglandin I2. FEBS Lett (1977) 0.81
Expression of histone and tubulin genes during spermatogenesis. Evidence of post-meiotic transcription. Exp Cell Res (1985) 0.81
High-level expression of active human cyclooxygenase-2 in insect cells. Arch Biochem Biophys (1994) 0.81
Factors associated with planned avoidance of alcohol-impaired driving in high-risk men. J Stud Alcohol (1999) 0.81
Regulation of the cellular expression of secretory and cytosolic phospholipases A2, and cyclooxygenase-2 by peptide growth factors. Biochim Biophys Acta (1998) 0.80
Prostaglandin I2 synthesis and elevation of cyclic AMP levels in 3T3 fibroblasts. Biochim Biophys Acta (1980) 0.80
Characterization of autocrine inducible prostaglandin H synthase-2 (PGHS-2) in human osteosarcoma cells. Inflamm Res (1997) 0.80
Human cytosolic phospholipase A2 expressed in insect cells is extensively phosphorylated on Ser-505. Biochim Biophys Acta (1995) 0.80
Diverse expression of cytosolic phospholipase A2, 5-lipoxygenase and prostaglandin H synthase 2 in acute pre-B-lymphocytic leukaemia cells. Br J Haematol (1995) 0.80
Cytogenetic and radiation hybrid mapping of human arachidonate 5-lipoxygenase-activating protein (ALOX5AP) to chromosome 13q12. Genomics (1999) 0.79
Relationship of cyclic-AMP levels in leukotriene B4-stimulated leukocytes to lysosomal enzyme release and the generation of superoxide anions. Biochim Biophys Acta (1984) 0.79
Leukotrienes A4 and B4 stimulate the formation of cyclic AMP in human leukocytes. FEBS Lett (1982) 0.79
Formation of novel biologically active leukotrienes by omega-oxidation in human leukocyte preparations. Adv Prostaglandin Thromboxane Leukot Res (1982) 0.79
Effects of leukotrienes on phenotypic properties and growth of arterial smooth muscle cells in primary culture. J Cell Sci (1989) 0.78
Phosphorylation of a group of high molecular weight basic nuclear proteins during spermatogenesis in the winter flounder. J Biol Chem (1981) 0.78
Effects of platelet aggregation and adenosine 3':5'-monophosphate on the synthesis of thromboxane B2 in human platelets. Adv Prostaglandin Thromboxane Res (1980) 0.78
Enhancement of leukocyte response to lipopolysaccharide by secretory group IIA phospholipase A2. J Leukoc Biol (1999) 0.78
Tenidap sodium inhibits secretory non-pancreatic phospholipase A(2) synthesis by foetal rat calvarial osteoblasts. Mediators Inflamm (1995) 0.77
Divergent effects of dihydropyridine and phenylalkylamine calcium channel antagonist classes on autonomic function in human hypertension. Hypertension (1995) 0.77
Expression of altered alpha2-adrenergic phenotypic traits in normotensive humans at genetic risk of hereditary (essential) hypertension. J Hypertens (1998) 0.77
Isolation and nucleotide sequence of a cloned cardionatrin cDNA. Biochem Biophys Res Commun (1984) 0.77
Inhibitors of arachidonic acid metabolism reduce DNA and nuclear fragmentation induced by TNF plus cycloheximide in U937 cells. Cell Death Differ (1997) 0.77
Sites of phosphorylation on the high molecular weight basic nuclear proteins of the winter flounder. J Biol Chem (1985) 0.77
Lipoxygenase products from polymorphonuclear leukocytes and epithelial cells of human saliva. Arch Biochem Biophys (1987) 0.76
Inhibition of prostaglandin synthesis in mouse 3T3 fibroblasts and human platelets by substituted phenols. Prostaglandins (1977) 0.76
Formation of diketopiperazines by Penicillium italicum isolated from oranges. Appl Microbiol (1974) 0.76
Formation and effects of leukotriene B4 in human lymphocytes. Int J Tissue React (1989) 0.76
Characterization of a leukotriene C4 export mechanism in human platelets: possible involvement of multidrug resistance-associated protein 1. J Lipid Res (1999) 0.76
Inhibition of intradental nerve excitability by leukotriene B4 and C4. Acta Physiol Scand (1984) 0.76
Selective inhibitors of COX-2. Agents Actions Suppl (1995) 0.76
Leukotriene B4: biosynthesis and role in lymphocytes. Adv Prostaglandin Thromboxane Leukot Res (1990) 0.76
Development and validation of an intact cell assay for protein tyrosine phosphatases using recombinant baculoviruses. Biochem Pharmacol (1999) 0.76
B-lymphocytic cell line Raji expresses the leukotriene A4 hydrolase gene but not the 5-lipoxygenase gene. Biochem Biophys Res Commun (1989) 0.75